Treating metastatic non-small cell lung cancer patients with immunotherapy plus ablative therapy increases progression-free survival. (Courtesy: Penn Medicine)
The past decade has witnessed the advent of modern immunotherapy. Monoclonal antibodies that target
You’ve reached the limit of what you can view on Physics World without registering
If you already have an account on Physics World, then please sign in to continue reading
If you do not yet have an account, please register so you can
Access more than 20 years of online content
Choose which e-mail newsletters you would like to receive
Tami Freeman
is an online editor for Physics World